SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

51,747.70 -1,625.37
(-3.05%)

Nikkei 225

10,127.96 160.61
(1.61%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

52.0221666

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

42.44

342.88

EPS(TTM)

Face Value()

Div & Yield %

1.51

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	375.64	365.47	396.53	329.49	303.63	274.32
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	375.64	365.47	396.53	329.49	303.63	274.32
Other Income	5.62	4.69	6.43	4.51	2.45	4.66
Stock Adjustments	-1.27	14.05	-16.46	9.67	1.11	6.40
Total Income	379.99	384.21	386.50	343.67	307.19	285.38
EXPENDITURE :
Raw Materials	166.58	185.49	182.37	170.02	159.74	149.54
Power & Fuel Cost	17.39	13.47	11.09	9.14	7.04	7.47
Employee Cost	56.41	50.81	46.47	38.63	34.48	34.58
Other Manufacturing Expenses	32.14	31.97	27.30	23.76	19.02	22.37
Selling & Administrative Expenses	52.04	51.66	55.69	54.44	43.70	40.96
Miscellaneous Expenses	6.54	6.03	5.95	5.24	9.12	6.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	331.10	339.42	328.87	301.23	273.11	260.94
Operating Profit	48.89	44.79	57.63	42.44	34.08	24.43
Interest	11.39	6.92	5.58	8.31	10.89	12.65
Gross Profit	37.50	37.87	52.05	34.13	23.19	11.78
Depreciation	19.89	14.83	16.13	14.84	14.61	13.27
Profit Before Tax	17.61	23.04	35.92	19.29	8.58	-1.49
Tax	4.45	0.83	6.28	3.40	0.02	-0.12
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.42	5.45	4.63	2.88	2.95	-3.10
Reported Net Profit	11.74	16.76	25.01	13.01	5.62	1.74
Extraordinary Items	0.00	-0.01	0.00	0.00	-3.39	-0.01
Adjusted Net Profit	11.74	16.77	25.01	13.01	9.01	1.75
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.49
P & L Balance brought forward	152.73	136.36	111.81	98.76	93.52	92.54
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.54	0.38	0.46	-0.05	0.39	1.24
P & L Balance carried down	163.94	152.73	136.36	111.81	98.76	93.52
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	2.41	3.44	5.13	8.01	3.46	1.08
Earnings Per Share(Adj)-Unit Curr	2.41	3.44	5.13	2.67	1.15	0.36
Book Value-Unit Curr	49.90	47.60	39.85	104.73	96.69	93.79
Book Value(Adj)-Unit Curr	49.90	47.60	39.85	34.91	32.23	31.26

71,947.55 -1,635.67 ( -2.22%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

51,747.70 -1,625.37 (-3.05%)

10,127.96 160.61 (1.61%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)